COMPARISON OF ANTI-XA LEVELS BETWEEN OBESE AND NON-OBESE CRITICALLY ILL PATIENTS RECEIVING UNFRACTIONATED HEPARIN THROMBOPROPHYLAXIS

被引:0
|
作者
Blum, Mark [1 ]
Park, Jayoung [2 ]
Wu, Wenchen [2 ]
Belchikov, Yuly [1 ]
Smith, Candace [2 ]
Barrera, Rafael [1 ]
机构
[1] Long Isl Jewish Med Ctr, Queens, NY 11004 USA
[2] St Johns Univ, Collegeville, MN 56321 USA
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
933
引用
收藏
页码:U254 / U254
页数:1
相关论文
共 50 条
  • [21] Evaluation of safety and effectiveness of standardized antifactor Xa-based unfractionated heparin protocols in obese versus non-obese patients
    Isherwood, Manuel
    Murphy, Michelle L.
    Bingham, Angela L.
    Siemianowski, Laura A.
    Hunter, Krystal
    Hollands, James M.
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2017, 43 (04) : 476 - 483
  • [22] Evaluation of safety and effectiveness of standardized antifactor Xa-based unfractionated heparin protocols in obese versus non-obese patients
    Manuel Isherwood
    Michelle L. Murphy
    Angela L. Bingham
    Laura A. Siemianowski
    Krystal Hunter
    James M. Hollands
    [J]. Journal of Thrombosis and Thrombolysis, 2017, 43 : 476 - 483
  • [23] Anti-Xa levels in critically ill children receiving enoxaparin for venothromboembolism prophylaxis
    Marshall, Amanda M.
    Trussell, Taylor M.
    Yee, Addison M.
    Malone, Mathew P.
    [J]. THROMBOSIS RESEARCH, 2021, 203 : 117 - 120
  • [24] CONTINUOUS SEDATION WITH MIDAZOLAM IN OBESE VS NON-OBESE CRITICALLY ILL PATIENTS
    Genkina, Yuliya
    Mancl, Erin
    Rech, Megan
    [J]. CRITICAL CARE MEDICINE, 2015, 43 (12)
  • [25] Comparison Between Activated Partial Thromboplastin Time and Anti-Xa Heparin Assays on Patients on Unfractionated Heparin Therapy
    Pearlman, Eugene
    Bibars, Wafi
    Willard, Jennifer
    Moore, Darlene
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 144 : A127 - A127
  • [26] Unfractionated heparin dosing for therapeutic anticoagulation in critically ill obese adults
    Hohner, E. M.
    Kruer, R. M.
    Gilmore, V. T.
    Streiff, M.
    Gibbs, H.
    [J]. JOURNAL OF CRITICAL CARE, 2015, 30 (02) : 395 - 399
  • [27] EVALUATION OF WEIGHT-BASED DOSING OF UNFRACTIONATED HEPARIN IN CRITICALLY ILL OBESE PATIENTS
    Adams, Hannah
    Righi, Angela
    Fowler, Melissa
    Patel, Jaimini
    [J]. CRITICAL CARE MEDICINE, 2020, 48
  • [28] Efficacy of standard dose unfractionated heparin for venous thromboembolism prophylaxis in morbidly obese and non-morbidly obese critically Ill patients
    Lee, Young R.
    Blanco, Delilah D.
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2017, 44 (03) : 386 - 391
  • [29] Efficacy of standard dose unfractionated heparin for venous thromboembolism prophylaxis in morbidly obese and non-morbidly obese critically Ill patients
    Young R. Lee
    Delilah D. Blanco
    [J]. Journal of Thrombosis and Thrombolysis, 2017, 44 : 386 - 391
  • [30] Evaluation of Time to Therapeutic Anticoagulation and Associated Outcomes in Critically Ill, Obese Patients With Pulmonary Embolism Receiving Unfractionated Heparin
    Sutton, Lauren H.
    Tellor, Bethany R.
    Pope, Hannah E.
    Riney, Jennifer N.
    Weaver, Katherine L.
    [J]. JOURNAL OF PHARMACY PRACTICE, 2021, 34 (03) : 438 - 444